MIM
GSK icon

Morningstar Investment Management’s GSK GSK Stock Holding History

Morningstar Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-139,467
Closed -$6.02M – 381
2025
Q3 		$6.02M Buy
+139,467
New +$5.45M 0.22% 117

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morningstar Investment Management's GSK Position: Q4 2025 in Review

Morningstar Investment Management sold out of GSK (GSK) in Q4 2025, closing a stake of 139,467 shares — an estimated $6.02M sold.

Morningstar Investment Management first reported a position in GSK in Q3 2025 and held it in 1 quarter. The position peaked at $6.02M in Q3 2025. 998 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Morningstar Investment Management reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • Morningstar Investment Management sold 139,467 GSK shares in Q4 2025, an estimated $6.02M.
  • Morningstar Investment Management first reported a position in GSK in Q3 2025 and held it in 1 quarter.
  • Morningstar Investment Management's GSK position peaked at $6.02M in Q3 2025.
  • 998 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Morningstar Investment Management's 13F filing for Q4 2025, filed 9 Feb 2026.